| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATIONS |
1 From the Division of Diabetes, Department of Medicine (MT, RB, MT, and HY-J), the Obesity Research Unit (AR), and the Department of Obstetrics and Gynecology (KT), University of Helsinki, Finland; the Department of Health and Functional Capacity, National Health Institute, Helsinki (AA and IS); and the Minerva Research Insitute, Helsinki (RB).
Background: Dietary fat has been reported to influence insulin sensitivity.
Objective: The objective of the study was to determine how identical weight loss (target: loss of 8% of body weight over 3–6 mo) in women taking orlistat or placebo combined with a hypocaloric diet influences body composition and insulin sensitivity.
Design: Forty-seven obese women [body mass index (in kg/m2): 32.1 ± 0.4] were randomly assigned to receive either orlistat (120 mg 3 times daily; n = 23) or placebo (n = 24) with a hypocaloric diet. Whole-body insulin sensitivity (insulin clamp technique), serum fatty acids, and body composition (magnetic resonance imaging) were measured before and after weight loss.
Results: The groups did not differ significantly at baseline with respect to age, body weight, intraabdominal and subcutaneous fat volumes, or insulin sensitivity. Weight loss did not differ significantly between the orlistat (7.3 ± 0.2 kg, or 8.3 ± 0.1%) and placebo (7.4 ± 0.2 kg, or 8.2 ± 0.1%) groups. Insulin sensitivity improved significantly (P < 0.001) and similarly after weight loss in the orlistat (from 4.0 ± 0.3 to 5.1 ± 0.3 mg · kg fat-free mass-1 · min-1) and placebo (from 4.4 ± 0.4 to 5.4 ± 0.4 mg · kg fat-free mass-1 · min-1) groups. Intraabdominal fat and subcutaneous fat decreased significantly in both groups, but the ratio of the 2 decreased significantly only in the orlistat group. The proportion of dihomo-
-linolenic acid (20:3n-6) in serum phospholipids was inversely related to insulin sensitivity both before (r = -0.48, P < 0.001) and after (r = -0.46, P < 0.001) weight loss, but it did not change significantly in either group.
Conclusions: Weight loss rather than inhibition of fat absorption enhances insulin sensitivity. A decrease in fat absorption by orlistat appears to favorably influence the ratio between intraabdominal and subcutaneous fat, which suggests that exogenous fat or its composition influences fat distribution.
Key Words: Fat intake • fatty acids • visceral fat • diet • nutrition
This article has been cited by other articles:
|
|
 |
|
  S. A Harrison and C. P. Day Benefits of lifestyle modification in NAFLD Gut, December 1, 2007; 56(12): 1760 - 1769. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsujita, H. Takaichi, T. Takaku, S. Aoyama, and J. Hiraki Antiobesity action of {epsilon}-polylysine, a potent inhibitor of pancreatic lipase J. Lipid Res., August 1, 2006; 47(8): 1852 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Westerbacka, K. Lammi, A.-M. Hakkinen, A. Rissanen, I. Salminen, A. Aro, and H. Yki-Jarvinen Dietary Fat Content Modifies Liver Fat in Overweight Nondiabetic Subjects J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2804 - 2809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tiikkainen, A.-M. Hakkinen, E. Korsheninnikova, T. Nyman, S. Makimattila, and H. Yki-Jarvinen Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes Diabetes, August 1, 2004; 53(8): 2169 - 2176. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
